slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 66,061-66,090
Pages 2,605
Rows per page 30
Component
66,061-66,090 of 78,138
83
TNWC = Trade Net Working Capital; CapEx = Capital Expenditure.Hugo Boss | Investor Presentation Deck | 99 slides · Hugo Boss
Conference presentation Investor relations 1 hit
94
Includes photos of employees holding pictures of themselves as children.Hugo Boss | Investor Presentation Deck | 99 slides · Hugo Boss
Conference presentation Investor relations 1 hit
16
The slide uses a split-screen layout with a black background for the rollout timeline and a photo background for the productivity metric.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations 1 hit
21
The slide uses a combination of bulleted strategic initiatives and regional performance metrics (sourcing volumes vs. sales).Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations 1 hit
28
The chart shows a net decline of 30 basis points.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
30
The chart uses a dual-axis approach: bars for absolute EUR million values and a line for percentage of sales.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
34
The slide uses a simple bar chart comparison between 2023 actuals and 2024 estimates.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · Action1 hit
37
The slide uses a simple bar chart visualization to compare 2023 actuals with 2024 estimates.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · Action1 hit
39
The chart uses a waterfall bridge to show the path from 61.5% margin to the 62-64% 'Claim 5' ambition range.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · Action1 hit
41
The slide uses a split-screen layout with key drivers on the left and a bar chart on the right.Hugo Boss | Results Presentation Deck | 44 slides · Hugo Boss
Conference presentation Investor relations Beat · Action1 hit
05
The slide uses a Gantt-style chart to represent clinical trial stages.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
07
The slide uses a structural diagram to map technical modifications to clinical outcomes.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution1 hit
10
Includes a biological pathway diagram showing B-cell maturation and a pyramid diagram showing the hierarchy of disease targeting.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
13
Uses a bar chart to compare CRS duration in days across four competitors, with NXC-201 highlighted as significantly lower.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
14
The slide uses a bar chart to compare neurotoxicity percentages and a table to compare clinical metrics like CRS onset and duration.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
15
The slide highlights NXC-201's 100% overall response rate and superior cardiac response compared to CAEL-101 and Birtamimab.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
16
The chart is a swimmer plot showing patient response duration, with an annotation indicating the target population for future enrollment.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
18
N-GENIUS TECHNOLOGY PLATFORM; NEXICART-1 Clinical Trial Data.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
21
Uses a combination of bar charts for preclinical data and a comparison table for clinical outcomes to demonstrate the superiority of the CD8 hinge optimization.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
22
The slide uses a schematic to compare HSL and LSH configurations, showing superior performance for HSL in expansion and cytotoxicity metrics.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
28
The slide uses a visual comparison of three treatment timelines to highlight the superior safety profile of NXC-201.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
34
Includes a comparative table of clinical outcomes (ORR, CR/sCR) for NXC-201 vs competitors.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
48
The slide uses a bubble chart to show clinical trial outcomes and a table to detail efficacy/safety metrics across treatment lines.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
49
The slide uses a combination of a conceptual chart and a data table to demonstrate efficacy and safety in heavily pre-treated patients.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
55
The slide uses a bar chart comparison to establish a benchmark for clinical efficacy in the IBD market.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
08
The slide uses a maturity model framework to map business units against a progression of profitability stages.Kakao | Results Presentation Deck | 48 slides · Kakao
Conference presentation Investor relations Beat · ProblemLoop · Logic Chain1 hit
27
The slide shows a stacked bar chart of revenue from 4Q22 to 4Q23 and a corresponding table detailing the business units within each segment.Kakao | Results Presentation Deck | 48 slides · Kakao
Conference presentation Investor relations Beat · Financials1 hit
40
The slide shows a bridge/reconciliation between two reporting standards (Earnings Release vs. Business Report) for goodwill impairment.Kakao | Results Presentation Deck | 48 slides · Kakao
Conference presentation Investor relations 1 hit
15
Includes images of the company's electric truck and school bus products.Lion Electric | Investor Presentation Deck | 32 slides · Lion Electric
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
17
Includes a bar chart showing revenue growth from 2021-2023 and a bulleted list of financial highlights.Lion Electric | Investor Presentation Deck | 32 slides · Lion Electric
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit